Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01087957 · ClinicalTrials.gov registry record · NA
WalkAide Compared to Ankle-Foot Orthosis (AFO) in Stroke Patients
A NA study, sponsored by Innovative Neurotronics.
- Completed
- Registry status
- NA
- Development phase
- 495
- Enrollment target
NCT01087957: Completed NA study, sponsored by Innovative Neurotronics.
NCT01087957 is a NA study that has completed, run by Innovative Neurotronics. The registered enrollment target is 495 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01087957, a NA study, has completed, sponsored by Innovative Neurotronics.
- COMPLETED
- Registry status
- NA
- Development phase
- 495 participants
- Enrollment target
Study Summary
To establish equivalence or incremental benefit to standard of care Ankle-Foot Orthosis (AFO) for patients with foot drop due to stroke, and to assess the functional improvement of ambulation and improved activities of daily living.
Primary Outcome
Improved ambulation status, specific to increase in gait velocity (m/s)
Interventions
- DEVICE WalkAide
- OTHER Ankle-Foot Orthosis (AFO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 495 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT01087957 record still lists
NCT01087957 is an interventional study that assigns participants to a tested intervention. The registered 495 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 2 interventions - of which WalkAide is the first listed.
NCT01087957 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01087957 about?
NCT01087957 is a clinical study titled "WalkAide Compared to Ankle-Foot Orthosis (AFO) in Stroke Patients". To establish equivalence or incremental benefit to standard of care Ankle-Foot Orthosis (AFO) for patients with foot drop due to stroke, and to assess the functional improvement of ambulation and improved activities of daily living.
What is the current status of trial NCT01087957?
This trial is currently completed. It is a NA study. The enrollment target is 495 participants. The study started on 2010-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01087957?
The interventions under investigation include: WalkAide (DEVICE), Ankle-Foot Orthosis (AFO) (OTHER).
Who is sponsoring clinical trial NCT01087957?
This trial is sponsored by Innovative Neurotronics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01087957's enrollment target sits among peer trials
495 213th of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127267 · 495 participants · Phase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- NCT06400472 · 495 participants · Phase 1
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- NCT05283720 · 496 participants · Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
- NCT06417775 · 496 participants · Phase 3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia